Our findings demonstrate that genetic deletion of tryptophan hydroxylase-1 produces a modest up-regulation of pulmonary SERT binding sites (i.e., 30–40% elevation) and an increase in the expression level of several genes implicated in the pathogenesis of PAH. The gene discussed is SLC6A4; the disease is pulmonary arterial hypertension.